MX2023007535A - Toxina t-2 conjugada para proteger contra la micotoxicosis. - Google Patents

Toxina t-2 conjugada para proteger contra la micotoxicosis.

Info

Publication number
MX2023007535A
MX2023007535A MX2023007535A MX2023007535A MX2023007535A MX 2023007535 A MX2023007535 A MX 2023007535A MX 2023007535 A MX2023007535 A MX 2023007535A MX 2023007535 A MX2023007535 A MX 2023007535A MX 2023007535 A MX2023007535 A MX 2023007535A
Authority
MX
Mexico
Prior art keywords
mycotoxicosis
toxin
conjugated
protect against
damage
Prior art date
Application number
MX2023007535A
Other languages
English (en)
Inventor
Maarten Hendrik Witvliet
Ruud Philip Antoon Maria Segers
Sietske Kooijman
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of MX2023007535A publication Critical patent/MX2023007535A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere al uso de la toxina T-2 (T2) conjugada en un método para proteger a un animal contra la micotoxicosis inducida por T2, en particular para proteger contra una disminución en el aumento de peso diario promedio, daño intestinal, daño en la piel y daño en el hocico, así uno o más de estos signos de micotoxicosis inducidos por T2 como resultado de la ingestión de T2.
MX2023007535A 2020-12-22 2021-12-21 Toxina t-2 conjugada para proteger contra la micotoxicosis. MX2023007535A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20216338 2020-12-22
PCT/EP2021/086950 WO2022136348A1 (en) 2020-12-22 2021-12-21 Conjugated t-2 toxin to protect against mycotoxicosis

Publications (1)

Publication Number Publication Date
MX2023007535A true MX2023007535A (es) 2023-07-10

Family

ID=73856721

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023007535A MX2023007535A (es) 2020-12-22 2021-12-21 Toxina t-2 conjugada para proteger contra la micotoxicosis.

Country Status (9)

Country Link
US (1) US20240024395A1 (es)
EP (1) EP4267190A1 (es)
JP (1) JP2023554135A (es)
CN (1) CN116710145A (es)
AU (1) AU2021406284A1 (es)
CA (1) CA3202834A1 (es)
CL (1) CL2023001817A1 (es)
MX (1) MX2023007535A (es)
WO (1) WO2022136348A1 (es)

Also Published As

Publication number Publication date
US20240024395A1 (en) 2024-01-25
JP2023554135A (ja) 2023-12-26
CA3202834A1 (en) 2022-06-30
CL2023001817A1 (es) 2024-03-08
EP4267190A1 (en) 2023-11-01
AU2021406284A9 (en) 2024-04-18
AU2021406284A1 (en) 2023-06-22
WO2022136348A1 (en) 2022-06-30
CN116710145A (zh) 2023-09-05

Similar Documents

Publication Publication Date Title
PH12020550489A1 (en) Gene targets for nitrogen fixation targeting for improving plant traits
PH12018501685A1 (en) Indole and azaindole haloallylamine derivative inhibitors of lysyl oxidases and uses thereof
EP3830127A4 (en) Muscle targeting complexes and uses thereof for treating pompe disease
MX2023000736A (es) Productos microbianos alimentados en directo.
PH12020551651A1 (en) Food protection of fruit, cereal and vegetable and derivatives
MX2018013865A (es) Composiciones cosmeticas prebioticas y uso de las composiciones cosmeticas prebioticas.
MX2023007535A (es) Toxina t-2 conjugada para proteger contra la micotoxicosis.
MX2021002787A (es) Composiciones de alimento animal y usos de las mismas.
MX2023007538A (es) Fumonisina conjugada para proteger contra la micotoxicosis.
PH12018550098A1 (en) Repellent and attractant composition for dichromatic animals
MX2021015837A (es) Desoxinivalenol conjugado para proteger contra micotoxicosis.
MX2022009293A (es) Formulaciones de pantalla solar con oxido metalico.
MX2020012882A (es) Extracto y composicion dermatologica que comprende el mismo, para tratamiento de piel sensible.
MX2020005682A (es) Extracto de helichrysum gymnocephalum para el tratamiento y/o la prevencion de dermatosis inflamatorias.
MX2019014815A (es) Composicion antimicrobiana que incluye un acido dihidroxamico y metodos de inhibicion del crecimiento microbiano que usan el mismo.
MX2023007625A (es) Aflatoxina b conjugada para proteger contra micotoxicosis.
MX2023007536A (es) Zearalenona conjugada para proteger contra micotoxicosis.
TH192017S (th) อุปกรณ์ทางการแพทย์
TH192020S (th) อุปกรณ์ทางการแพทย์
TH192021S (th) อุปกรณ์ทางการแพทย์
MX2021010099A (es) Tratamiento microbiano.
TH193656S (th) อุปกรณ์สำหรับช่วยผสมพันธุ์สัตว์
TH193654S (th) อุปกรณ์สำหรับช่วยผสมพันธุ์สัตว์
MX2018003668A (es) Uso de la genisteina como modulador de la microbiota intestinal.
UA131540U (uk) Мармелад желейний "кизиловий"